Leading scientist awarded £500,000 to investigate new blood test which could help spot bowel cancer sooner

Professor Ian Tomlinson, director of the Institute of Cancer and Genomic Sciences

A leading University of Birmingham scientist has been awarded a £500,000 grant from Cancer Research UK to investigate whether a new blood-based screening test could detect bowel cancer earlier.

Professor Ian Tomlinson, director of the Institute of Cancer and Genomic Sciences at the University of Birmingham, has teamed up with colleagues in the UK and Denmark to investigate whether early signs of bowel cancer can be spotted in people’s blood stream.

The NHS bowel screening test looks for traces of blood in people’s faeces which can be present when people have bowel cancer or pre-cancerous changes called polyps.

Currently, if blood is detected, the person may be asked to take the test again or meet with a specialist to discuss having a colonoscopy – which looks at the inside of the large bowel.

Prof Tomlinson said that, if successful, the research could lead to a blood test being offered to people who had already had a positive screening test to enable doctors to distinguish between those in need of an urgent colonoscopy and those who could have less urgent investigation.

“Bowel cancer screening is improving in terms of its accuracy and convenience,” said Prof Tomlinson. “We want to make screening even better by offering a blood test to people who have had a positive screening test. We hope this will eventually allow people most likely to have bowel cancer to be identified and treated even earlier.”

In the longer term it is hoped the research might form the basis of a comprehensive study to see how the test might be used as a primary screening method.

In England, people between the ages of 60 and 74 are invited for bowel cancer screening yet figures show that that more than 40 per cent of those eligible didn’t complete the test in 2017/18.

In 2019 NHS England will roll out a new screening test called the faecal immunochemical test (FIT) which requires just one small faeces sample rather than several which were needed previously. The new test is easier to use and so more people are expected to take it up. But, like any test, bowel screening isn’t perfect so people are still advised to tell their doctor if they notice any changes to their body.

Dr David Crosby, Head of Early Detection Research at Cancer Research UK, said: “We are excited to support this pilot study investigating the utility of signals in patients’ blood to improve bowel cancer screening. The validation of whether these types of tests can detect and distinguish polyps from cancer is an important next step for future studies.”

Ends

For more information please contact:

  1. Emma McKinney, Communications Manager (Health Sciences), University of Birmingham, tel: +44 (0) 121 414 6681, or contact the press office out of hours on +44 (0) 7789 921 165.
  2. Paula Young, senior media relations officer at Cancer Research UK, on 07786 510438. (On Wednesdays please try Jane Redman on 07918 650670).

Notes to editors:

* Only 58% of eligible individuals in England participate in the bowel screening programme. PHE Fingertips. Persons, 60-74, screening for bowel cancer within 6 months of invitation (Uptake, %). Available from: https://fingertips.phe.org.uk/profile/cancerservices

  • The University of Birmingham is ranked amongst the world’s top 100 institutions, its work brings people from across the world to Birmingham, including researchers and teachers and more than 6,500 international students from over 150 countries.
  • Cancer Research UK is the world’s leading cancer charity dedicated to saving lives through research. Its pioneering work into the prevention, diagnosis and treatment of cancer has helped save millions of lives. Cancer Research UK receives no government funding for its life-saving research. Every step it makes towards beating cancer relies on vital donations from the public. It has been at the heart of the progress that has already seen survival in the UK double in the last 40 years. Today, 2 in 4 people survive their cancer for at least 10 years. Cancer Research UK’s ambition is to accelerate progress so that by 2034, 3 in 4 people will survive their cancer for at least 10 years. Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses. Together with its partners and supporters, Cancer Research UK's vision is to bring forward the day when all cancers are cured. For further information about Cancer Research UK's work or to find out how to support the charity, please call 0300 123 1022.